Indo-Bangla Pharmaceuticals Limited announced earnings results for the third quarter ended March 31, 2019. For the third quarter, the company announced sales was BDT 208.708 million compared to BDT 161.952 million a year ago. Net income was BDT 44.028 million compared to BDT 25.639 million a year ago. Basic earnings per share was BDT 0.43 compared to BDT 0.35 a year ago. For the nine months, sales was BDT 563.996 million compared to BDT 482.283 million a year ago. Net income was BDT 109.816 million compared to BDT 74.353 million a year ago. Basic earnings per share was BDT 1.13 compared to BDT 1.02 a year ago.